Consumer Discretionary·Automobile Manufacturers·$1.4T
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.12 | N/A | +266.67% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.12 | N/A | +266.67% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings surprise, highlighting ongoing efforts to enhance production capabilities. They emphasized a commitment to long-term growth.
We are pleased with our EPS performance this quarter.
Our focus remains on scaling production and improving efficiency.
Tesla's strong EPS performance indicates better-than-expected profitability, which contributed to a slight increase in stock price. The lack of revenue data and guidance may leave investors cautious, but the positive EPS surprise suggests effective cost management. Overall, the market reacted favorably, reflecting confidence in Tesla's ongoing operational improvements.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013